Tag: Review
-
Week In Review: Two Billion-Dollar Deals As 2023 Nears End – Hansoh-GSK; Nona-Pfizer
PeopleImages Deals and Financings GSK acquired ex-Greater China rights to a second ADC from Jiangsu’s Hansoh Pharma in a $1.7 billion agreement (see story). GSK’s latest acquisition, HS-20093, is a B7-H3 targeted antibody-drug conjugate (ADC) with a topoisomerase inhibitor (TOPOi) payload that is in China Phase I/II trials for solid tumor cancers. Hansoh will receive…
-
Preferreds Weekly Review: AAIC Delists Its Bonds
Darren415 Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity from both the bottom-up, highlighting individual news and events, as well as the top-down, providing an overview of the broader market. We also try to add some historical context as well as relevant themes…
-
CEF Weekly Review: Why Covered Call CEFs Are Not 'Equities At A Discount'
Torsten Asmus Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (“CEF”) market activity from both the bottom-up – highlighting individual fund news and events – as well as the top-down – providing an overview of the broader market. We also try to provide some historical context as well…
-
16 Best Rooftops In London For Stunning Pictures (Review With Photos)
Are you looking for the best rooftops in London for Insta-worthy photos? If so, this is the only list you’ll need! London is one of my favorite cities in the world. There are so many fun things to do in London to fit any budget or interest. From taking a ride on the London Eye to…